CD163 and cancer: Thus, the numbers of CD68+ macrophages, as well as the numbers of macrophages positive for M2 markers (CD163 and CD204) in borderline and malignant tumors were significantly higher in both serous and mucinous ovarian tumors than in benign tumors (213).